Inhibition of prostaglandin action and bone resorption by copper.
Open Access
- 1 December 1984
- journal article
- research article
- Published by Elsevier in Annals of the Rheumatic Diseases
- Vol. 43 (6) , 841-846
- https://doi.org/10.1136/ard.43.6.841
Abstract
Mouse calvaria were maintained in organ culture without serum additives. The effects of Cu2+ on bone resorption and on the synthesis and action of prostaglandins were studied. Non-toxic concentrations of copper sulphate (5 microM) were found to decrease active resorption, measured by 45Ca release, to 54% control values (p less than 0.001), while prostaglandin F (PGF), prostaglandin E2 (PGE2), and 6-keto-prostaglandin F1 alpha, (6-keto-PGF1 alpha), determined by radioimmunoassay, were increased above controls (p less than 0.05). These effects of Cu2+ on prostaglandin synthesis were confirmed by the isolation and quantitation of [3H]-labelled metabolites released from calvaria which had been pre-labelled with [3H]-arachidonic acid. PGE2, PGF2 alpha, 6-keto-PGF1 alpha, and thromboxane B2 (TxB2) were all higher in copper-exposed calvaria, but their relative amounts remained unchanged. There was no evidence that Cu2+ influenced the mobilisation of [3H]-arachidonic acid from prelabelled calvaria. The stimulation of bone resorption by exogenous prostaglandins was decreased in the presence of Cu2+ (p less than 0.005), while parathormone-mediated bone resorption was virtually unaffected. Cu2+ also increased the inhibition of bone resorption seen with indomethacin (p less than 0.05). In addition to the effects of the metal on prostaglandin action Cu2+ also decreased beta-glucuronidase activity in the media to 86% of the control values (p less than 0.001). The action of Cu2+ in inhibiting bone resorption in vitro appears complex but does not involve inhibition of prostaglandin synthesis. It is likely that Cu2+ has more than one inhibitory locus.This publication has 26 references indexed in Scilit:
- Lipophilic copper(II) formulations: Some correlations between their composition and anti-inflammatory/anti-arthritic activity when applied to the skin of ratsInflammation Research, 1982
- Anti-inflammatory properties of copper implants in the rat paw edema: A preliminary studyInflammation Research, 1981
- Cyclooxygenase products of arachidonic acid metabolism by mouse bone in organ cultureBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1980
- Concerning the role of endogenous copper in the acute inflammatory processInflammation Research, 1979
- Adjuvant Arthritis in young copper-deficient ratsInflammation Research, 1978
- Carrageenan oedema in copper-deficient ratsInflammation Research, 1978
- Synovial fluid copper and related variables in rheumatoid and degenerative arthritis.Annals of the Rheumatic Diseases, 1978
- Serum copper and caeruloplasmin in ankylosing spondylitis, systemic sclerosis, and morpheaAnnals of the Rheumatic Diseases, 1976
- The role of copper in prostaglandin synthesisBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1973
- Alterations in Tissue and Serum Ceruloplasmin Concentration Associated with InflammationJournal of Dental Research, 1967